Key result
Men with chronic HF show ~25% higher risk of death or HF admission than women.
Why the study?
The authors aimed to reveal sex differences in heart failure outcomes using an unselected health insurance claims database, focusing particularly on co-morbidities and medication.
Are there sex differences in the composite outcome of all-cause mortality or HF admission among patients with chronic heart failure?
Cohort (n=25,776)
Are there sex differences in the composite outcome of all-cause mortality or HF admission among patients with chronic heart failure?
Hazard Ratio: 1.25 (95% CI 1.19–1.3)
Absolute Event Rate: 35.1% vs 31.8%
In a large Dutch cohort of chronic heart failure patients, men had a 25% higher risk of death or HF admission than women, and the impact of co-morbidities on outcomes was stronger in women.
May support sex-specific HF risk models; leaves open whether comorbidity management should differ by sex.
AIMS: Health insurance claims (HIC) databases in the Netherlands capture unselected patient populations, which makes them suitable for epidemiological research on sex differences. Based on a HIC database, we aimed to reveal sex differences in heart failure (HF) outcomes, with particular focus on co-morbidities and medication. METHODS AND RESULTS: The Achmea HIC database included 14 517 men and 11 259 (45%) women with a diagnosis treatment code for chronic HF by January 2015. We related their sex, co-morbidities, and medication adherence (medication possession rate >0.8) with the primary endpoint (PE) of all-cause mortality or HF admission during a median follow-up of 3.3 years, using Cox regression. Median age of men and women was 72 and 76 years, respectively. Prevalence of co-morbidities and use of disease-modifying drugs was higher in men; however, medication adherence was similar. At the end of follow-up, 35.1% men and 31.8% women had reached the PE. The adjusted hazard ratio for men was 1.25 (95% confidence interval: 1.19-1.30). A broad range of co-morbidities was associated with the PE. Overall, these associations were stronger in women than in men, particularly for renal insufficiency, chronic obstructive pulmonary disease/asthma, and diabetes. Non-adherence to disease-modifying drugs was related with a higher incidence of the PE, with similar effects between sexes. CONCLUSIONS: In a representative sample of the Dutch population, as captured in a HIC database, men with chronic HF had a 25% higher incidence of death or HF admission than women. The impact of co-morbidities on the outcome was sex dependent, while medication adherence was not.
No takes yet. Share an insight, caveat, or question.
Gürgöze et al. (2020) conducted a cohort in Chronic heart failure (n=25,776). Male sex vs. Female sex was evaluated on All-cause mortality or heart failure admission (HR 1.25, 95% CI 1.19-1.30). Men with chronic heart failure had a higher incidence of death or HF admission than women (35.1% vs 31.8%; HR 1.25, 95% CI 1.19-1.30), while the impact of co-morbidities was stronger in women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: